Tied with Cabenuva for second place was Amgen’s Lumakras, which was approved in 2021 for non-small cell lung cancer and boasted impressive therapeutic and R&D scores, but fell behind both ...

Two weeks after Amgen reported the top-line result of its CodeBreak-200 trial of Lumakras in lung cancer, the data has been presented in abstract form at ESMO, showing a 34% improvement in ...

Amgen is facing a slowdown in uptake of its first-to-market KRAS inhibitor Lumakras as a second-line therapy for KRAS-mutated non-small cell lung cancer (NSCLC), so is understandably excited by ...

The Nexon EV reigns triumphant over the Windsor in our rolling acceleration test. From 20-80kph, the Tata EV outperformed the Windsor by 0.2 seconds. In the 40-100kph dash, the gap widened further ...

Jack Ma, co-founder of Chinese e-commerce giant Alibaba, speaks in Paris in 2019. Chinese e-commerce giant Alibaba highlighted its AI ambitions as it reported strong results for its third quarter ...

Overall survival was statistically significantly improved in adults treated with tislelizumab/chemotherapy compared with placebo/chemotherapy. The Food and Drug ...

From the March/April 2025 issue of Car and Driver. You'd think the sight of a new MG might attract more attention, whether it was spied carving up the winding roads of rural Scotland or whizzing ...

Issued on behalf of Oncolytics Biotech Inc. At the ASCO GI event, Oncolytics shared that in relapsed anal cancer, 4 out of 12 evaluable patients achieved a partial response for a response rate of ...

Class 10 Social Science Important Questions: Scoring well in the CBSE Class 10 Social Science Board Exam 2025 requires strong preparation, especially for 3-mark and 5-mark questions, which carry ...

The first seven-seat SUV sold by MG in Australia – the 2025 MG QS – has been revealed in government documents ahead of a local showroom arrival due by the middle of this year. But whereas the ...